We are live on
!
Find out more
Thompson Siegel & Walmsley Portfolio holdings
AUM
$5.57B
Turnover
15.37%
1-Year Est. Return
9.46%
This Fund
S&P 500
This Quarter
Est. Return
+6.89%
1 Year Est. Return
+9.46%
3 Year Est. Return
+32.41%
5 Year Est. Return
+38.31%
10 Year Est. Return
+103.24%
AUM
$5.57B
AUM Growth
-$133M
(-2.3%)
Cap. Flow
-$380M
Cap. Flow
% of AUM
-6.81%
Top 10 Holdings %
Top 10 Hldgs %
15.34%
Holding
462
New
44
Increased
118
Reduced
232
Closed
27
Avg Time Held Equity + Options
5.2
years
Top 10 Avg Time Held Equity + Options
1.7
years
Top 20 Avg Time Held Equity + Options
1.2
years
Avg Time Held Equity only
5.2
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$72.2M |
| 2 |
Occidental Petroleum
OXY
|
+$47M |
| 3 |
Ryan Specialty Holdings
RYAN
|
+$39.9M |
| 4 |
CoStar Group
CSGP
|
+$38.8M |
| 5 |
Charter Communications
CHTR
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TD Synnex
SNX
|
+$57.5M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$50.1M |
| 3 |
Centene
CNC
|
+$46.6M |
| 4 |
Molina Healthcare
MOH
|
+$44.8M |
| 5 |
Linde
LIN
|
+$41.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.57% |
| 2 | Healthcare | 13.98% |
| 3 | Consumer Discretionary | 9.78% |
| 4 | Industrials | 9.47% |
| 5 | Consumer Staples | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
NVIDIA
NVDA
$5.24T
| $38.5M | 0.69% |
192,606
-5,129
| -3% | -$1.05M |
2013 Q3
51 quarters
|
|
52
Bio-Rad Laboratories Class A
BIO
$9.52B
| $38.1M | 0.68% |
129,881
-46,584
| -26% | -$13.2M |
2022 Q3
15 quarters
|
|
53
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.6B
| $37.7M | 0.68% |
749,748
+93,450
| +14% | +$4.7M |
2021 Q2
20 quarters
|
|
54
Constellation Brands
STZ
$22.2B
| $36.3M | 0.65% |
260,686
-32,549
| -11% | -$4.84M |
2025 Q3
3 quarters
|
|
55
Merck
MRK
$362B
| $35.2M | 0.63% |
274,133
-568
| -0.2% | -$66.5K |
2013 Q2
52 quarters
|
|
|
56
Molina Healthcare
MOH
$10.9B
| $35.1M | 0.63% |
153,426
-247,276
| -62% | -$44.8M |
2025 Q4
2 quarters
|
|
57
Perrigo
PRGO
$2.28B
| $34.5M | 0.62% |
3,318,826
-435,074
| -12% | -$4.79M |
2021 Q2
20 quarters
|
|
|
58
TD Synnex
SNX
$19.9B
| $32M | 0.57% |
119,558
-238,684
| -67% | -$57.5M |
2021 Q4
18 quarters
|
|
59
iShares Russell Mid-Cap Value ETF
IWS
$15.4B
| $32M | 0.57% |
194,138
-27,372
| -12% | -$4.32M |
2013 Q4
50 quarters
|
|
60
SiriusXM
SIRI
$9.15B
| $31.7M | 0.57% |
1,072,555
-1,492,010
| -58% | -$40.1M |
2024 Q3
7 quarters
|
|
61
News Corp Class A
NWSA
$16.2B
| $31.7M | 0.57% |
1,274,887
-559,613
| -31% | -$14.5M |
2013 Q3
51 quarters
|
|
62
Corpay
CPAY
$26B
| $30.7M | 0.55% |
92,103
-29,793
| -24% | -$9.9M |
2020 Q2
24 quarters
|
|
63
National Fuel Gas
NFG
$7.6B
| $30.4M | 0.55% |
394,075
+296,355
| +303% | +$24.5M |
2022 Q4
14 quarters
|
|
64
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $30.4M | 0.55% |
40,693
-204
| -0.5% | -$148K |
2013 Q2
52 quarters
|
|
65
Microsoft
MSFT
$3.92T
| $29.6M | 0.53% |
79,259
-2,409
| -3% | -$975K |
2013 Q2
52 quarters
|
|
66
Berkshire Hathaway Class B
BRK.B
$1.13T
| $28.4M | 0.51% |
56,699
+2,816
| +5% | +$1.35M |
2013 Q2
52 quarters
|
|
67
Crown Holdings
CCK
$12.5B
| $28.2M | 0.51% |
252,328
-170,906
| -40% | -$17.3M |
2024 Q4
6 quarters
|
|
68
Biogen
BIIB
$34.9B
| $28.2M | 0.51% |
130,512
-117,831
| -47% | -$22.5M |
2025 Q1
5 quarters
|
|
69
PPG Industries
PPG
$24B
| $28.2M | 0.51% |
232,132
-68,449
| -23% | -$7.62M |
2025 Q2
4 quarters
|
|
70
Brown-Forman Class B
BF.B
$13.2B
| $26.9M | 0.48% |
1,008,726
-50,919
| -5% | -$1.37M |
2025 Q3
3 quarters
|
|
71
Vanguard S&P 500 ETF
VOO
$1.04T
| $26.6M | 0.48% |
38,801
-572
| -1% | -$381K |
2017 Q1
37 quarters
|
|
|
72
Linde
LIN
$230B
| $24.8M | 0.45% |
47,778
-81,445
| -63% | -$41.3M |
2018 Q4
30 quarters
|
|
73
Liberty Global Class A
LBTYA
$2.72B
| $24.4M | 0.44% |
2,147,988
-150,779
| -7% | -$1.8M |
2021 Q4
18 quarters
|
|
74
Clarivate
CLVT
$1.1B
| $23.6M | 0.42% |
10,925,657
-3,461,468
| -24% | -$8.46M |
2023 Q1
13 quarters
|
|
75
HP
HPQ
$27.1B
| $23.5M | 0.42% |
1,071,805
-613,673
| -36% | -$13.6M |
2026 Q1
1 quarter
|
|
Similar funds
LP
Thompson Siegel & Walmsley's Q2 2026 Portfolio in Review
As of Q2 2026, Thompson Siegel & Walmsley held 462 positions worth $5.57B, down 2.3% from $5.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Thompson Siegel & Walmsley withdrew a net $380M in Q2 2026, closing 27 positions and reducing 232 holdings. Its most notable exit was Best Buy, an estimated $7.42M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Thompson Siegel & Walmsley opened a new position in Zoetis worth $55.1M.
- Thompson Siegel & Walmsley's largest Q2 2026 buy was Zoetis: 766,798 shares worth $55.1M.
- Thompson Siegel & Walmsley added most to Occidental Petroleum in Q2 2026, an estimated $47M increase.
- Thompson Siegel & Walmsley's biggest Q2 2026 reduction was TD Synnex, cutting an estimated $57.5M.
- Thompson Siegel & Walmsley fully exited Best Buy in Q2 2026, selling an estimated $7.42M.
- Thompson Siegel & Walmsley's ten largest holdings make up 15% of its $5.57B portfolio in Q2 2026.
- Thompson Siegel & Walmsley opened 44 new positions and closed 27 in Q2 2026.
- Thompson Siegel & Walmsley's portfolio value fell 2.3% quarter-over-quarter to $5.57B.
Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.